Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma
Science Advances · 23.01.2026 · 12 (4)
DOI: 10.1126/sciadv.ady0550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 23.01.2026. Verfasst von Emma D Wrenn und 12 weiteren Autor:innen. Beteiligte Einrichtung: Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Transforming Growth Factor beta2, Autocrine Communication, Transcription, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Association for Cancer Research, National Cancer Institute.
Abstract (Originalsprache)
Subpopulations of cancer-associated fibroblast (CAF)–like tumor cells deposit extracellular matrix (ECM) proteins that support Ewing sarcoma (EwS) progression and metastasis. We previously showed a hallmark of CAF-like EwS cells is their hybrid transcriptional state wherein the driver fusion oncogene, EWS::FLI1, maintains activation of proliferative programs but loses capacity to repress mesenchymal genes. Here, we studied primary patient tumors and cell line models to identify molecular drivers of this hybrid state. Our data reveal that hybrid EwS cells are induced and maintained by a transforming growth factor–β (TGFβ) signaling positive feedback loop. Hybrid cells derepress TGFBR2 and up-regulate expression and secretion of TGFβ2 to sustain pathway activation and ECM deposition. Although TGFβ ligands can potently induce growth arrest in cells of epithelial origin, we show that TGFβ1 and TGFβ2 promote cell invasion of EwS cells without affecting proliferation. Thus, stroma-derived and tumor-derived TGFβ ligands induce and maintain hybrid EwS cells to promote pro-metastatic cell phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA.
- Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
- School of Medicine, University of Washington, Seattle, WA, USA.
- Department of Pediatrics, University of Washington, Seattle, WA, USA.
- Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
ORCID-Profile: Emma D Wrenn, Jacob C Harris, Patricia A Lipson, Nicolas M Garcia, Aya Miyaki, Steven C Chen, Jim M Olson, Kelly M Bailey, Elizabeth R Lawlor
Förderung
- NCI NIH HHS
- American Association for Cancer Research
- National Cancer Institute
- Washington Research Foundation
- Sam Day Foundation
- 1 Million 4 Anna Foundation
- Seattle Children’s Research Institute Seed Funds
Zitieren
APA
Wrenn, E. D., Harris, J. C., Apfelbaum, A. A., Valenti, J. R., Lipson, P. A., Walter, S. I., Garcia, N. M., Miyaki, A., Chen, S. C., Olson, J. M., Price, J. P., Bailey, K. M., & Lawlor, E. R. (2026). Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma. Science Advances, 12(4). https://doi.org/10.1126/sciadv.ady0550
Vancouver
Wrenn ED, Harris JC, Apfelbaum AA, Valenti JR, Lipson PA, Walter SI, et al. Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma. Science Advances. 2026;12(4). doi:10.1126/sciadv.ady0550
BibTeX
@article{Wrenn2026,
author = {Wrenn, Emma D and Harris, Jacob C and Apfelbaum, April A and Valenti, Jonah R and Lipson, Patricia A and Walter, Stephanie I and Garcia, Nicolas M and Miyaki, Aya and Chen, Steven C and Olson, Jim M and Price, Jason P and Bailey, Kelly M and Lawlor, Elizabeth R},
title = {Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {4},
doi = {10.1126/sciadv.ady0550}
}
EUVIMED